$177 Million is the total value of SILVERARC CAPITAL MANAGEMENT, LLC's 82 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 58.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $8,598,000 | +56.4% | 61,897 | +9.3% | 4.86% | +98.2% |
| VCYT | Buy | VERACYTE INC | $8,340,000 | +38.3% | 179,548 | +19.0% | 4.72% | +75.3% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $8,127,000 | +33.3% | 45,941 | +21.7% | 4.60% | +68.9% |
| MRUS | Buy | MERUS N V | $7,611,000 | +12.6% | 345,964 | +7.8% | 4.30% | +42.7% |
| AMYT | Buy | AMRYT PHARMA PLCsponsored ads | $6,218,000 | +12.3% | 516,221 | +13.1% | 3.52% | +42.3% |
| HZNP | Buy | HORIZON THERAPEUTICS PUB L | $5,747,000 | +22.7% | 52,469 | +4.9% | 3.25% | +55.5% |
| COGT | Buy | COGENT BIOSCIENCES INC | $5,701,000 | +254.5% | 677,900 | +242.0% | 3.22% | +349.5% |
| IMTX | Buy | IMMATICS N.V | $5,692,000 | +69.4% | 437,866 | +51.3% | 3.22% | +114.7% |
| FULC | New | FULCRUM THERAPEUTICS INC | $5,238,000 | – | 185,691 | +100.0% | 2.96% | – |
| NXTC | Buy | NEXTCURE INC | $4,862,000 | +112.0% | 721,302 | +152.6% | 2.75% | +168.7% |
| INSM | Sell | INSMED INC | $4,808,000 | -4.8% | 174,588 | -1.6% | 2.72% | +20.7% |
| RACB | Sell | RESEARCH ALLIANCE CORP II | $4,663,000 | -7.3% | 473,396 | -4.5% | 2.64% | +17.6% |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $3,911,000 | +42.6% | 21,189 | +38.6% | 2.21% | +80.8% |
| ITCI | Sell | INTRA-CELLULAR THERAPIES INC | $3,798,000 | -17.8% | 101,890 | -10.0% | 2.15% | +4.1% |
| CERS | Buy | CERUS CORP | $3,772,000 | +614.4% | 619,369 | +3213.7% | 2.13% | +807.2% |
| IMGN | Sell | IMMUNOGEN INC | $3,685,000 | -32.4% | 649,919 | -21.5% | 2.08% | -14.4% |
| SRRA | Buy | SIERRA ONCOLOGY INC | $3,584,000 | +32.2% | 163,486 | +17.4% | 2.03% | +67.4% |
| MORF | Sell | MORPHIC HLDG INC | $3,268,000 | -45.2% | 57,704 | -44.4% | 1.85% | -30.5% |
| ITOS | Buy | ITEOS THERAPEUTICS INC | $3,157,000 | +63.0% | 116,931 | +54.9% | 1.78% | +106.6% |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $3,120,000 | -5.9% | 173,327 | -8.2% | 1.76% | +19.4% |
| ARVN | New | ARVINAS INC | $3,061,000 | – | 37,249 | +100.0% | 1.73% | – |
| LPTX | New | LEAP THERAPEUTICS INC | $2,486,000 | – | 620,000 | +100.0% | 1.40% | – |
| HALO | Sell | HALOZYME THERAPEUTICS INC | $2,448,000 | -19.2% | 60,170 | -9.8% | 1.38% | +2.5% |
| CCXI | Buy | CHEMOCENTRYX INCput | $2,380,000 | +77.7% | 139,200 | +39.2% | 1.35% | +125.5% |
| BLU | Buy | BELLUS HEALTH INC NEW | $2,241,000 | +243.2% | 365,000 | +73.9% | 1.27% | +335.4% |
| HLXA | Sell | HELIX ACQUISITION CORP | $2,224,000 | -8.2% | 223,906 | -4.3% | 1.26% | +16.4% |
| CLDX | Buy | CELLDEX THERAPEUTICS INC NEW | $2,065,000 | -29.4% | 38,243 | +285.5% | 1.17% | -10.6% |
| ELOX | Sell | ELOXX PHARMACEUTICALS INC | $2,054,000 | -45.3% | 1,259,840 | -33.3% | 1.16% | -30.7% |
| CYCC | Buy | CYCLACEL PHARMACEUTICALS INC | $2,048,000 | +34.1% | 388,632 | +50.7% | 1.16% | +70.0% |
| SGEN | Buy | SEAGEN INC | $1,995,000 | +120.4% | 11,749 | +105.0% | 1.13% | +179.2% |
| New | ERASCA INC | $1,976,000 | – | 93,122 | +100.0% | 1.12% | – | |
| OTIC | Buy | OTONOMY INC | $1,953,000 | -8.1% | 1,017,048 | +6.7% | 1.10% | +16.5% |
| VTGN | Buy | VISTAGEN THERAPEUTICS INC | $1,939,000 | 0.0% | 707,733 | +15.0% | 1.10% | +26.7% |
| MCRB | Buy | SERES THERAPEUTICS INC | $1,913,000 | +25.5% | 274,833 | +330.0% | 1.08% | +59.1% |
| BNTC | Buy | BENITEC BIOPHARMA INC | $1,778,000 | -10.5% | 498,009 | +6.6% | 1.00% | +13.4% |
| CYTK | New | CYTOKINETICS INC | $1,762,000 | – | 49,309 | +100.0% | 1.00% | – |
| VRDN | Buy | VIRIDIAN THERAPEUTICS INC | $1,745,000 | +236.2% | 106,078 | +273.5% | 0.99% | +327.3% |
| LHDX | New | LUCIRA HEALTH INC | $1,678,000 | – | 220,758 | +100.0% | 0.95% | – |
| ZNTL | Sell | ZENTALIS PHARMACEUTICALS INC | $1,590,000 | -13.9% | 23,855 | -31.3% | 0.90% | +9.1% |
| STXS | Sell | STEREOTAXIS INC | $1,569,000 | -46.9% | 291,696 | -4.8% | 0.89% | -32.6% |
| JNCE | Sell | JOUNCE THERAPEUTICS INC | $1,550,000 | -9.0% | 208,559 | -16.8% | 0.88% | +15.3% |
| CGEN | New | COMPUGEN LTDcall | $1,481,000 | – | 248,000 | +100.0% | 0.84% | – |
| PYPD | Buy | POLYPID LTD | $1,426,000 | +1.9% | 183,230 | +18.5% | 0.81% | +29.2% |
| ADMS | Sell | ADAMAS PHARMACEUTICALS INC | $1,414,000 | -50.3% | 288,042 | -46.5% | 0.80% | -37.0% |
| EYPT | Sell | EYEPOINT PHARMACEUTICALS INC | $1,347,000 | -38.2% | 129,290 | -46.6% | 0.76% | -21.5% |
| VRAY | Buy | VIEWRAY INC | $1,334,000 | +114.1% | 185,035 | +96.0% | 0.75% | +171.2% |
| DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $1,266,000 | -7.2% | 37,249 | -0.0% | 0.72% | +17.8% |
| BIIB | New | BIOGEN INC | $1,242,000 | – | 4,389 | +100.0% | 0.70% | – |
| CGEN | Sell | COMPUGEN LTDord | $1,215,000 | -29.8% | 203,532 | -2.7% | 0.69% | -11.0% |
| ARNA | Sell | ARENA PHARMACEUTICALS INC | $1,106,000 | -21.2% | 18,581 | -9.7% | 0.62% | -0.2% |
| MSAC | Sell | MEDICUS SCIENCES ACQUISITION | $1,073,000 | -70.2% | 110,040 | -70.5% | 0.61% | -62.2% |
| KURA | Sell | KURA ONCOLOGY INC | $1,060,000 | -38.4% | 56,614 | -31.4% | 0.60% | -22.0% |
| DNAA | Sell | SOCIAL CAP SUVRETTA HLDS CRP | $1,055,000 | -58.3% | 106,000 | -57.6% | 0.60% | -47.1% |
| DNAB | Sell | SOCIAL CAP SUVRETTA HLDS CRP | $1,047,000 | -58.6% | 106,000 | -57.6% | 0.59% | -47.5% |
| DNAD | Sell | SOCIAL CAP SUVRETTA HLDS CP | $1,040,000 | -58.8% | 106,000 | -57.6% | 0.59% | -47.8% |
| DNAC | Sell | SOCIAL CAP SUVRETTA HLD CRPI | $1,039,000 | -58.9% | 106,000 | -57.6% | 0.59% | -47.9% |
| CRNX | New | CRINETICS PHARMACEUTICALS IN | $1,039,000 | – | 49,382 | +100.0% | 0.59% | – |
| ATHA | Sell | ATHIRA PHARMA INC | $998,000 | -17.4% | 106,388 | -9.8% | 0.56% | +4.6% |
| MREO | Sell | MEREO BIOPHARMA GROUP PLCads | $885,000 | -31.2% | 365,661 | -9.9% | 0.50% | -12.9% |
| RNLX | Sell | RENALYTIX PLCads | $742,000 | -80.9% | 37,000 | -70.7% | 0.42% | -75.9% |
| NTLA | New | INTELLIA THERAPEUTICS INC | $664,000 | – | 4,950 | +100.0% | 0.38% | – |
| EVGN | Sell | EVOGENE LTD | $656,000 | -46.9% | 248,327 | -31.3% | 0.37% | -32.7% |
| DRNA | Sell | DICERNA PHARMACEUTICALS INC | $626,000 | -92.7% | 31,040 | -86.5% | 0.35% | -90.7% |
| PNT | New | POINT BIOPHARMA GLOBAL INC | $552,000 | – | 71,729 | +100.0% | 0.31% | – |
| CLXPF | New | CYBIN INC | $549,000 | – | 250,000 | +100.0% | 0.31% | – |
| GH | Sell | GUARDANT HEALTH INC | $527,000 | -9.1% | 4,218 | -9.7% | 0.30% | +15.1% |
| CABA | New | CABALETTA BIO INC | $511,000 | – | 42,022 | +100.0% | 0.29% | – |
| ISEE | New | IVERIC BIO INC | $487,000 | – | 30,000 | +100.0% | 0.28% | – |
| CRIS | Sell | CURIS INC | $486,000 | -76.8% | 62,070 | -76.1% | 0.28% | -70.6% |
| AYLA | Buy | AYALA PHARMACEUTICALS INC | $464,000 | +95.0% | 40,956 | +75.3% | 0.26% | +147.2% |
| EVLO | New | EVELO BIOSCIENCES INCput | $434,000 | – | 61,700 | +100.0% | 0.24% | – |
| CALA | Buy | CALITHERA BIOSCIENCES INC | $406,000 | +515.2% | 186,245 | +493.5% | 0.23% | +693.1% |
| KROS | New | KEROS THERAPEUTICS INC | $396,000 | – | 10,000 | +100.0% | 0.22% | – |
| SURF | Sell | SURFACE ONCOLOGY INC | $379,000 | -46.2% | 50,000 | -47.1% | 0.21% | -31.8% |
| RAPT | Sell | RAPT THERAPEUTICS INC | $366,000 | -75.6% | 11,796 | -75.0% | 0.21% | -69.1% |
| ARCT | New | ARCTURUS THERAPEUTICS HLDGS | $297,000 | – | 6,208 | +100.0% | 0.17% | – |
| XENE | New | XENON PHARMACEUTICALS INC | $297,000 | – | 19,432 | +100.0% | 0.17% | – |
| AFMD | Sell | AFFIMED N V | $292,000 | -83.0% | 47,182 | -76.7% | 0.16% | -78.5% |
| New | ADAGIO THERAPEUTICS INC | $211,000 | – | 5,000 | +100.0% | 0.12% | – | |
| New | RENOVACOR INC*w exp 99/99/999 | $42,000 | – | 104,828 | +100.0% | 0.02% | – | |
| CBIO | New | CATALYST BIOSCIENCES INC | $41,000 | – | 10,000 | +100.0% | 0.02% | – |
| MSACW | MEDICUS SCIENCES ACQUISITION*w exp 02/12/202 | $35,000 | -30.0% | 49,990 | 0.0% | 0.02% | -9.1% | |
| PHGE | Exit | BIOMX INC | $0 | – | -14,207 | -100.0% | -0.04% | – |
| CHAQWS | Exit | CHARDAN HEALTHCR ACQSTN 2 CO*w exp 03/05/202 | $0 | – | -104,828 | -100.0% | -0.04% | – |
| ETON | Exit | ETON PHARMACEUTICALS INC | $0 | – | -18,691 | -100.0% | -0.05% | – |
| FMTX | Exit | FORMA THERAPEUTICS HLDGS INC | $0 | – | -9,679 | -100.0% | -0.11% | – |
| MDGL | Exit | MADRIGAL PHARMACEUTICALS INC | $0 | – | -2,480 | -100.0% | -0.11% | – |
| QURE | Exit | UNIQURE NV | $0 | – | -9,346 | -100.0% | -0.13% | – |
| MDNA | Exit | MEDICENNA THERAPEUTICS CORP | $0 | – | -110,515 | -100.0% | -0.15% | – |
| KALV | Exit | KALVISTA PHARMACEUTICALS INC | $0 | – | -14,882 | -100.0% | -0.16% | – |
| Exit | CATABASIS PHARMACEUTICALS IN | $0 | – | -188,777 | -100.0% | -0.18% | – | |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -7,009 | -100.0% | -0.20% | – |
| RCKT | Exit | ROCKET PHARMACEUTICALS INC | $0 | – | -10,293 | -100.0% | -0.20% | – |
| SLRX | Exit | SALARIUS PHARMACEUTICALS INC | $0 | – | -471,885 | -100.0% | -0.22% | – |
| ETNB | Exit | 89BIO INC | $0 | – | -28,032 | -100.0% | -0.23% | – |
| SAGE | Exit | SAGE THERAPEUTICS INCcall | $0 | – | -9,300 | -100.0% | -0.24% | – |
| SNDX | Exit | SYNDAX PHARMACEUTICALS INC | $0 | – | -34,727 | -100.0% | -0.27% | – |
| ODT | Exit | ODONATE THERAPEUTICS INC | $0 | – | -186,680 | -100.0% | -0.29% | – |
| ASND | Exit | ASCENDIS PHARMA A/Ssponsored adr | $0 | – | -5,599 | -100.0% | -0.33% | – |
| ARDX | Exit | ARDELYX INC | $0 | – | -99,237 | -100.0% | -0.34% | – |
| AKRO | Exit | AKERO THERAPEUTICS INC | $0 | – | -33,028 | -100.0% | -0.36% | – |
| WVE | Exit | WAVE LIFE SCIENCES LTD | $0 | – | -123,972 | -100.0% | -0.37% | – |
| Exit | TRILLIUM THERAPEUTICS INC | $0 | – | -95,190 | -100.0% | -0.41% | – | |
| DCTH | Exit | DELCATH SYS INC | $0 | – | -99,189 | -100.0% | -0.56% | – |
| RETA | Exit | REATA PHARMACEUTICALS INCcl a | $0 | – | -9,346 | -100.0% | -0.59% | – |
| RLMD | Exit | RELMADA THERAPEUTICS INC | $0 | – | -46,729 | -100.0% | -0.67% | – |
| RCUS | Exit | ARCUS BIOSCIENCES INCput | $0 | – | -60,400 | -100.0% | -0.74% | – |
| CERE | Exit | CEREVEL THERAPEUTICS HLDNG I | $0 | – | -15,000 | -100.0% | -0.74% | – |
| MRSN | Exit | MERSANA THERAPEUTICS INC | $0 | – | -125,123 | -100.0% | -0.76% | – |
| CGEM | Exit | CULLINAN ONCOLOGY INC | $0 | – | -75,732 | -100.0% | -0.87% | – |
| ALDX | Exit | ALDEYRA THERAPEUTICS INC | $0 | – | -192,345 | -100.0% | -0.97% | – |
| MCRB | Exit | SERES THERAPEUTICS INCcall | $0 | – | -122,700 | -100.0% | -1.30% | – |
| TCRR | Exit | TCR2 THERAPEUTICS INC | $0 | – | -188,142 | -100.0% | -1.38% | – |
| VSTM | Exit | VERASTEM INC | $0 | – | -1,049,357 | -100.0% | -1.90% | – |
| MGNX | Exit | MACROGENICS INC | $0 | – | -176,915 | -100.0% | -2.12% | – |
| XBI | Exit | SPDR SER TRcall | $0 | – | -94,400 | -100.0% | -5.70% | – |
| KDNY | Exit | CHINOOK THERAPEUTICS INC | $0 | – | -14,158 | -100.0% | -5.70% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| INTRA-CELLULAR THERAPIES INC | 12 | Q3 2023 | 7.8% |
| IMMUNOGEN INC | 12 | Q3 2023 | 8.3% |
| Morphic Holding Inc | 12 | Q3 2023 | 4.5% |
| UNUM THERAPEUTICS INC | 12 | Q3 2023 | 3.2% |
| INSMED INC | 12 | Q3 2023 | 3.5% |
| UNITED THERAPEUTICS CORP DEL | 12 | Q3 2023 | 2.2% |
| MERUS N V | 11 | Q3 2023 | 5.1% |
| VERACYTE INC | 11 | Q3 2023 | 4.9% |
| EVOGENE LTD | 11 | Q3 2023 | 1.6% |
| COMPUGEN LTD | 11 | Q3 2023 | 1.1% |
View SILVERARC CAPITAL MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Benitec Biopharma Inc.Sold out | February 08, 2023 | 0 | 0.0% |
| DELCATH SYSTEMS, INC.Sold out | February 08, 2022 | 0 | 0.0% |
View SILVERARC CAPITAL MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G/A | 2023-02-08 |
| 13F-HR | 2022-10-28 |
View SILVERARC CAPITAL MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.